CCND1 and Miyoshi myopathy: The translocation between chromosome 11 and 14 is one of the well-known genetic abnormalities and is present in ~20% of newly diagnosed patients with MM (NDMM), followed by t(4;14) (10% to 20%), t(14;16) (5%), t(14;20) and t(6;14) which lead to the overexpression of CCND1, FGFR3/MMSET, MAF and CCND3 oncogenes, respectively [17,19].